The new acquisition is Lilly's ninth since the start of the year, coming just a few weeks after it agreed to buy psychedelic ...

A new, universal definition for a heart attack or myocardial infarction (MI) recognises that there are many different ...

Since 2001, International Overdose Day has been observed as a moment to remember those lost to overdose and renew society’s ...

Since taking effect in August 2024, the EU AI Act (Regulation (EU) 2024/1689) has categorised AI tools by risk level. For ...

The UK government has published a list of the best- and worst-performing NHS trusts in England for the first time, part of a drive to end the 'postcode lottery' of care. Health Secretary Wes Streeting ...

AstraZeneca has reported the first clinical data with its oral PCSK9 inhibitor AZD0780, which it hopes could offer an alternative to current injectable drugs used to lower cholesterol. The new data – ...

A digital therapy that could reduce the severity of chronic tic disorders like Tourette syndrome has been recommended for use by the NHS for the first time. The technology, known as ORBIT (Online ...

Japanese pharma group Otsuka has signed an agreement to acquire Canada's Mindset Pharma, a specialist in psychedelic medicines for neuropsychiatric disorders. The all-cash deal – worth around C$80 ...

Developing new drugs and therapies is a contact sport for research sites. Investigators are on the frontlines, meeting and ...

As the European Society of Cardiology Congress 2026 kicks off today, UK biopharma company Isomab has presented landmark ...

After a series of bumps in the road, Roviant and Priovant Therapeutics have finally secured US approval for the once-daily oral TYK2/JAK1 inhibitor, Lisraya (brepocitinib), for adults with ...

The MHS technology is Anthropic’s first tool designed to operate in the physical world. According to the Financial Times, ...